Two Sides of the Same Coin: How Cancer May Potentially Protect the Brain

What if two of the most feared diseases of our time were somehow connected - not as allies, but as opposites?

Cancer and Alzheimer’s disease are usually discussed at opposite ends of the medical spectrum: one marked by uncontrolled cell growth, the other by relentless cell loss, yet scientists are uncovering a fascinating link between the two.

Over the years many professionals have made an unusual observation within cancer patients where, almost none of them went on to develop Alzheimer after being diagnosed. While there is no epidemiological data to draw a clear divide, a 2020 meta-analysis of data from more than 9.6 million people found that cancer diagnosis was associated with an 11% decreased incidence of Alzheimer’s disease. Now while these statistics alone could make one conclude an inverse relationship between the two, many researchers highlighted that there were many other factors contributing to the data, the biggest one being that most cancer patients don't tend to live long enough to reach the age range of developing Alzheimer's.

But this clearly did not stop curious minds from digging deep into the observation.

Recent studies have shown a potential answer as to why this mysterious observation came into play. This research was carried out through mice implanted with human cells and as hypothesised these mice showed signs of being less Alzheimer's prone. But how?

Before delving into this, let us first understand the various components of the mechanism.

1. Cystatin C is a protein that helps protect the brain and is linked to breaking down harmful protein clumps.
2. Amyloid plaques are misfolded protein clumps that typically cause Alzheimer's by disrupting communication between neurons and triggering inflammation that damages brain cells, leading to memory loss and cognitive decline.
3. TREM2 is the molecule that helps in the breakdown of amyloid plaque which has been found to be activated by Cystatin C.

In this case researchers state that the peripheral cancer cells may secrete cystatin C, thus an individual with cancer could potentially have higher levels of Cystatin C compared to the typical human being. This greater amount of Cystatin C may enter the brain, stimulating the activation of TREM2 and hence breaking down larger amounts of Amyloid plaques ultimately reducing the potential risk of Alzheimer's in the individual.

Most of the research is preclinical, only conducted in mice, whose biology and brain systems differ significantly from humans. Therefore, while this research could be incredibly revolutionary it will be some time before we can confirm whether the same mechanisms apply in humans and explore their therapeutic potential.

In this dance of life and disease, cancer and Alzheimer's may just be two sides of the same coin.

Bibliography:

1.https://www.pacificlifere.com/insights-articles/Cancer-and-Alzheimers-A-curious-inverse-relationship.html

2.https://www.nationalgeographic.com/health/article/alzheimers-disease-cancer-immune-system

3.https://www.nature.com/articles/d41586-026-00222-7?utm_source=Live+Audience&utm_campaign=f4f2b22b7f-nature-briefing-daily-20260123&utm_medium=email&utm_term=0_-33f35e09ea-500815543

4.https://theconversation.com/people-who-survive-cancers-are-less-likely-to-develop-alzheimers-this-might-be-why-274304

5.https://www.foxnews.com/health/does-cancer-reduce-alzheimers-risk-new-study-explores-connection